Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GLP-1 RAs have been shown to result in increased residual gastric contents (RGCs) in patients undergoing EGDs and poor Boston Bowel Preparation Scores (BBPSs) in those undergoing colonoscopies
Silveira and colleagues (2023) highlighted in a retrospective chart review semaglutide-treated patients were 5 times more likely to have residual gastric content on elective esophagogastroduodenoscopies than non-semaglutide-treated patients
Mild, temporary sensations at the injection site may occur
Why does eating slowly matter on a GLP-1
Monitor protein consumption closely
Am J Physiol Endocrinol Metab 299 , E730740
US$ 21.08
US$ 21.57
US$ 21.16
US$ 25.27
